Benefits and limitations of different study designs for long-acting antiretroviral therapy among people living with HIV with viremia

J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26093. doi: 10.1002/jia2.26093.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • HIV Infections* / drug therapy
  • Humans
  • Viremia* / drug therapy